Newman B, Austin MA, Lee M, King MC. Inheritance of breast cancer: evidence for autosomal dominant transmission
in high risk families. Proc Natl Acad Sci U S A.1988;85:1-5.
Claus EB, Risch N, Thompson WD. Genetic analysis of breast cancer in the cancer and steroid hormone
study. Am J Hum Genet.1991;48:232-241.
Hall JM, Lee MK, Newman B.
et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science.1990;250:1684-1689.
Narod SA, Feunteun J, Lynch HT.
et al. Familial breast-ovarian cancer locus on chromosome 17q12-23. Lancet.1991;338:82-83.
Miki Y, Swensen J, Shattuck-Eidens D.
et al. A strong candidate for the breast and ovarian cancer susceptibility
gene BRCA1. Science.1994;266:66-71.
Couch FJ, Weber BL. Mutations and polymorphisms in the familial early-onset breast cancer
(BRCA1) gene: Breast Cancer Information Core. Hum Mutat.1996;8:8-18.
Castilla LH, Couch FJ, Erdos MR.
et al. Mutations in the BRCA1 gene in families with
early-onset breast cancer. Nat Genet.1994;8:387-391.
Friedman LS, Ostermeyer EA, Szabo CI.
et al. Confirmation of BRCA1 by analysis of germline
mutations linked to breast and ovarian cancer in ten families. Nat Genet.1994;8:399-404.
Serova O, Montagna M, Torchard D.
et al. A high incidence of BRCA1 mutations in 20
breast-ovarian cancer families. Am J Hum Genet.1996;58:42-51.
Struewing JP, Brody LC, Erdos MR.
et al. Detection of eight BRCA1 mutations in 10 breast-ovarian
cancer families, including 1 family with male breast cancer. Am J Hum Genet.1995;57:1-7.
Szabo CI, King MC. Population genetics of BRCA1 and BRCA2. Am J Hum Genet.1997;60:1013-1020.
Easton DF, Bishop DT, Ford D, Crockford G.and the The Breast Cancer Linkage Consortium. Genetic linkage analysis in familial breast and ovarian cancer: results
from 214 families. Am J Hum Genet.1993;52:678-701.
Narod SA, Ford D, Devilee P.
et al. An evaluation of genetic heterogeneity in 145 breast-ovarian cancer
families. Am J Hum Genet.1995;56:254-264.
Struewing JP, Abeliovich D, Peretz T.
et al. The carrier frequency of the BRCA1 185delAG
mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet.1995;11:198-200.
Tonin P, Serova O, Lenoir G.
et al. BRCA1 in Ashkenazi Jewish women. Am J Hum Genet.1995;57:189.
Struewing JP, Hartge P, Wacholder S.
et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med.1997;336:1401-1408.
Langston AA, Malone KE, Thompson JD, Daling JR, Ostrander EA. BRCA1 mutations in a population-based sample
of young women with breast cancer. N Engl J Med.1996;334:137-142.
FitzGerald MG, MacDonald DJ, Krainer M.
et al. Incidence of BRCA1 germline mutations in early
onset breast cancer. N Engl J Med.1996;334:143-149.
Daling JR, Malone KE, Voigt LF, White E, Weiss NS. Risk of breast cancer among young women: relationship to induced abortion. J Natl Cancer Inst.1994;86:1584-1592.
Brinton LA, Daling JR, Liff JM.
et al. Oral contraceptives and breast cancer risk among younger women. J Natl Cancer Inst.1995;87:827-835.
Waksberg J. Sampling methods for random digit dialing. J Am Stat Assoc.1978;73:40-46.
Simard J, Tonin P, Durocher F.
et al. Common origins of BRCA1 mutations in Canadian
breast and ovarian cancer families. Nat Genet.1994;8:392-398.
Berman DB, Wagner-Costalas J, Schultz DC, Lynch HT, Daly M, Godwin AK. Two distinct origins of a common BRCA1 mutation
in breast-ovarian cancer families: a genetic study of 15185delAG-mutation
kindreds. Am J Hum Genet.1996;58:1166-1176.
Couch FJ, Garber J, Kiousis S.
et al. Genetic analysis of eight breast-ovarian cancer families with suspected BRCA1 mutations. J Natl Cancer Inst Monogr.1995;17:9-14.
Krainer M, Silva-Arrieta S, FitzGerald MG.
et al. Differential contribution of BRCA1 and BRCA2 to early-onset breast cancer. N Engl J Med.1997;336:1416-1421.
Shattuck-Eidens D, Oliphant A, McClure M.
et al. BRCA1 sequence analysis in women at high risk
for susceptibility mutations. JAMA.1997;278:1242-1250.
Couch FJ, DeShano ML, Blackwood A.
et al. BRCA1 mutations in women attending clinics
that evaluate the risk of breast cancer. N Engl J Med.1997;336:1409-1415.
Whittemore AS, Gong G, Itnyre J. Prevalence and contribution of BRCA1 mutations
in breast cancer and ovarian cancer: results from three US population-based
case-control studies of ovarian cancer. Am J Hum Genet.1997;60:496-504.
Ford D, Easton DF, Peto J. Estimates of the gene frequency of BRCA1 and
its contribution to breast and ovarian cancer incidence. Am J Hum Genet.1995;57:1457-1462.
Stoppa-Lyonnet D, Laurent-Puig P, Essioux L.
et al. BRCA1 sequence variations in 160 individuals
referred to a breast/ovarian family cancer clinic. Am J Hum Genet.1997;60:1021-1030.
Hakansson S, Johannsson O, Johannson U.
et al. Moderate frequency of BRCA1 and BRCA2 germline mutations in Scandinavian familial breast cancer. Am J Hum Genet.1997;60:1068-1078.
Mathew CG, Solomon E, Hodgson SV. Re: Breast cancer and BRCA1 mutations. N Engl J Med.1996;334:1198.
Jacquemier J, Eisinger F, Birnbaum D, Sobol H. Histoprognostic grade in BRCA1-associated
breast cancer. Lancet.1995;345:1503.
Malone KE, Daling JR, Weiss NS, McKnight B, White E, Voigt LF. Family history and survival of young women with invasive breast cancer. Cancer.1996;78:1417-1425.
Porter DE, Cohen BB, Wallace MR.
et al. Breast cancer incidence and survival in probable carriers of BRCA1 gene mutation in families linked to BRCA1 on chromosome 17q12-21. Br J Surg.1994;81:1512-1515.
Johannsson OT, Idvall I, Anderson C.
et al. Tumour biological features of BRCA1-induced
breast and ovarian cancer. Eur J Cancer.1997;33:362-371.
Jordanova A, Kalaydjieva L, Savov A.
et al. SSCP analysis: a blind sensitivity trial. Hum Mutat.1997;10:65-70.